Biotechnology
Antengene to Present Preclinical Data Demonstrating the Synergistic Effect of the Combination of XPO1 and mTORC1/2 Inhibition for the Treatment of Triple-Hit DLBCL at AACR Annual Meeting 2021
SHANGHAI and GAITHERSBURG, Md., March 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolog...
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
HANGZHOU, China, March 22, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("INF"), a biopharmaceutical innovation and partnership company, announced today the completion of a625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020. The Series A ...
Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq
SHANGHAI, March 20, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price isUS$ 17.00/ADS. The stock opened at US$19.55/ADS and closed atUS$18.49/ADS on the first trading day, up 8.8%, with a market...
Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders
INCHEON, South Korea, March 18, 2021 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announced a strong year in 2020 as it reported1 trillion won in
target sales within just a decade at its 10th Annual General Meeting (AGM) on
March 19th Korea time.
MGI Contributes to Africa's COVID-19 Response Efforts
SHENZHEN, China, March 18, 2021 /PRNewswire/ -- MGI
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program
VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...
Microba Life Sciences appoints experienced executive Mark Capone to the Board
BRISBANE, Australia, March 18, 2021 /PRNewswire/ -- Microba Life Sciences
Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software
PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ -- Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige's comprehensive portfo...
Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells
BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...
111, Inc. Enters into First-Ever Strategic Partnership with BeiGene
SHANGHAI, March 17, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, announced today it has entered into a strategic cooperation agreem...
GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19
SINGAPORE, March 17, 2021 /PRNewswire/ -- GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have ...
Transcenta Continues to Push the Boundary of Cell Culture Productivity by Achieving > 6 g/L PER Day Volumetric Productivity in Continuous Perfusion Platform
SUZHOU and HANGZHOU, China, March 16, 2021 /PRNewswire/ -- Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced a major breakthrough in its continuous perfusion cell culture p...
GenScript receives "Best Contract Research Organization Award" in the 4th Annual Asia-Pacific Bioprocessing Excellence Awards Ceremony 2021
SINGAPORE, March 16, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Research Organization Award" on the 4th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021held on 16th March 2021. The award follows GenScri...
VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
AUSTIN, Texas, March 16, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, March 23, at 8:00 a.m. Eastern time to discuss its financial and operating results for the full fiscal year 2020, in addition to providing ...
QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines
Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...
Microba Life Sciences partners with Unilever to target sleep through the gut microbiome
BRISBANE, Australia, March 15, 2021 /PRNewswire/ -- Experts in gut microbiome
analysis, Microba Life Sciences
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs
VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...
Antengene Included in the Shenzhen-Hong Kong Stock Connect
SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09